- Home
- SYRE vs UAN Comparison
SYRE vs UAN Comparison
Compare SYRE & UAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- UAN
- Stock Information
- Founded
- SYRE 2013
- UAN 2007
- Country
- SYRE United States
- UAN United States
- Employees
- SYRE N/A
- UAN N/A
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- UAN Agricultural Chemicals
- Sector
- SYRE Health Care
- UAN Industrials
- Exchange
- SYRE Nasdaq
- UAN Nasdaq
- Market Cap
- SYRE 1.1B
- UAN 943.7M
- IPO Year
- SYRE 2016
- UAN 2011
- Fundamental
- Price
- SYRE $15.86
- UAN $87.43
- Analyst Decision
- SYRE Buy
- UAN
- Analyst Count
- SYRE 5
- UAN 0
- Target Price
- SYRE $55.00
- UAN N/A
- AVG Volume (30 Days)
- SYRE 414.7K
- UAN 16.3K
- Earning Date
- SYRE 11-06-2025
- UAN 10-27-2025
- Dividend Yield
- SYRE N/A
- UAN 7.81%
- EPS Growth
- SYRE N/A
- UAN 77.68
- EPS
- SYRE N/A
- UAN 8.32
- Revenue
- SYRE N/A
- UAN $576,184,000.00
- Revenue This Year
- SYRE N/A
- UAN N/A
- Revenue Next Year
- SYRE N/A
- UAN N/A
- P/E Ratio
- SYRE N/A
- UAN $10.26
- Revenue Growth
- SYRE N/A
- UAN 8.15
- 52 Week Low
- SYRE $10.91
- UAN $62.94
- 52 Week High
- SYRE $40.26
- UAN $98.99
- Technical
- Relative Strength Index (RSI)
- SYRE 42.99
- UAN 42.58
- Support Level
- SYRE $15.80
- UAN $84.13
- Resistance Level
- SYRE $17.58
- UAN $90.70
- Average True Range (ATR)
- SYRE 0.74
- UAN 1.62
- MACD
- SYRE -0.11
- UAN -0.36
- Stochastic Oscillator
- SYRE 9.78
- UAN 46.67
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About UAN CVR Partners LP Common Units representing Limited Partner Interests
CVR Partners LP is a manufacturer and supplier of nitrogen fertilizer products. Its principal products include Urea Ammonium Nitrate (UAN) and ammonia. The company market ammonia products to industrial and agricultural customers and UAN products to agricultural customers. The primary geographic markets for its fertilizer products are Kansas, Missouri, Nebraska, Iowa, Illinois, Colorado, and Texas. The company's product sales are heavily weighted toward UAN.